Skip to main content
Top
Published in: Journal of Translational Medicine 1/2011

Open Access 01-12-2011 | Editorial

Translational Medicine is developing in China: A new venue for collaboration

Authors: Xiangdong Wang, Ena Wang, Francesco M Marincola

Published in: Journal of Translational Medicine | Issue 1/2011

Login to get access

Abstract

Translational Medicine is an emerging area comprising multidisciplinary Research from basic sciences to medical applications well summarized by the Bench-to-Beside concept; this entails close collaboration between clinicians and basic scientists across institutes. We further clarified that Translational Medicine should be regarded as a two-way road: Bench-to-Bedside and Bedside-to-Bench, to complement testing of novel therapeutic strategies in humans with feedback understanding of how they respond to them. It is, therefore, critical and important to define and promote Translational Medicine among clinicians, basic Researchers, biotechnologists, politicians, ethicists, sociologists, investors and coordinate these efforts among different Countries, fostering aspects germane only to this type of Research such as, as recently discussed, biotechnology entrepreneurship. Translational Medicine as an inter-disciplinary science is developing rapidly and widely and, in this article, we will place a special emphasis on China.
Literature
2.
go back to reference Littman BH, Di Mario L, Plebani M, Marincola FM: What's next in Translational Medicine?. Clin Sci (Lond). 2007, 112: 217-227. 10.1042/CS20060108.CrossRef Littman BH, Di Mario L, Plebani M, Marincola FM: What's next in Translational Medicine?. Clin Sci (Lond). 2007, 112: 217-227. 10.1042/CS20060108.CrossRef
3.
4.
go back to reference Watson PH, Wilson-McManus JE, Barnes RO, Giesz SC, Png A, Hegele RG, Brinkman JN, Mackenzie IR, Huntsman DG, Junker A: Evolutionary concepts in biobanking - the BC BioLibrary. J Transl Med. 2009, 7: 95-10.1186/1479-5876-7-95.PubMedCentralCrossRefPubMed Watson PH, Wilson-McManus JE, Barnes RO, Giesz SC, Png A, Hegele RG, Brinkman JN, Mackenzie IR, Huntsman DG, Junker A: Evolutionary concepts in biobanking - the BC BioLibrary. J Transl Med. 2009, 7: 95-10.1186/1479-5876-7-95.PubMedCentralCrossRefPubMed
5.
go back to reference Szalma S, Koka V, Khasanova T, Perakslis ED: Effective knowledge management in translational medicine. J Transl Med. 2010, 8: 68-10.1186/1479-5876-8-68.PubMedCentralCrossRefPubMed Szalma S, Koka V, Khasanova T, Perakslis ED: Effective knowledge management in translational medicine. J Transl Med. 2010, 8: 68-10.1186/1479-5876-8-68.PubMedCentralCrossRefPubMed
7.
go back to reference Ferte C, Andre F, Soria JC: Molecular circuits of solid tumors: prognostic and predictive tools for bedside use. Nat Rev Clin Oncol. 2010, 7: 367-380. 10.1038/nrclinonc.2010.84.CrossRefPubMed Ferte C, Andre F, Soria JC: Molecular circuits of solid tumors: prognostic and predictive tools for bedside use. Nat Rev Clin Oncol. 2010, 7: 367-380. 10.1038/nrclinonc.2010.84.CrossRefPubMed
8.
go back to reference Ascierto PA, Streicher HZ, Sznol M: Melanoma: a model for testing new agents in combination therapies. J Transl Med. 2010, 8: 38-10.1186/1479-5876-8-38.PubMedCentralCrossRefPubMed Ascierto PA, Streicher HZ, Sznol M: Melanoma: a model for testing new agents in combination therapies. J Transl Med. 2010, 8: 38-10.1186/1479-5876-8-38.PubMedCentralCrossRefPubMed
14.
go back to reference Mankoff SP, Brander C, Ferrone S, Marincola FM: Lost in translation: obstacles to Translational Medicine. J Transl Med. 2004, 2: 14-10.1186/1479-5876-2-14.PubMedCentralCrossRefPubMed Mankoff SP, Brander C, Ferrone S, Marincola FM: Lost in translation: obstacles to Translational Medicine. J Transl Med. 2004, 2: 14-10.1186/1479-5876-2-14.PubMedCentralCrossRefPubMed
18.
go back to reference Romero P, Fox BA: Announcing the tumor immunology and biological cancer therapy section (edited by iSBTc) of the Journal of Translational Medicine. J Transl Med. 2009, 7: 80-10.1186/1479-5876-7-80.PubMedCentralCrossRefPubMed Romero P, Fox BA: Announcing the tumor immunology and biological cancer therapy section (edited by iSBTc) of the Journal of Translational Medicine. J Transl Med. 2009, 7: 80-10.1186/1479-5876-7-80.PubMedCentralCrossRefPubMed
19.
go back to reference Vidal-Vanaclocha F, Witz IP: Introducing the cancer microenvironment section of Journal of Translational Medicine. J Transl Med. 2010, 8: 60-10.1186/1479-5876-8-60.PubMedCentralCrossRefPubMed Vidal-Vanaclocha F, Witz IP: Introducing the cancer microenvironment section of Journal of Translational Medicine. J Transl Med. 2010, 8: 60-10.1186/1479-5876-8-60.PubMedCentralCrossRefPubMed
21.
go back to reference Mintzberg H: Organizational design, fashion or fit?. Harvard Business Rev. 1981, 59: 103-116. Mintzberg H: Organizational design, fashion or fit?. Harvard Business Rev. 1981, 59: 103-116.
22.
go back to reference Ablin RJ, Marincola FM, Natali PG: The "Excellence in Translational Medicine" and "Bedside-to-Bench" Awards 2008-09. J Transl Med. 2010, 8: 95-10.1186/1479-5876-8-95.PubMedCentralCrossRefPubMed Ablin RJ, Marincola FM, Natali PG: The "Excellence in Translational Medicine" and "Bedside-to-Bench" Awards 2008-09. J Transl Med. 2010, 8: 95-10.1186/1479-5876-8-95.PubMedCentralCrossRefPubMed
23.
go back to reference Van EL, Marincola FM, Strohm J: Bridging the divide between science and journalism. J Transl Med. 2010, 8: 25-10.1186/1479-5876-8-25.CrossRef Van EL, Marincola FM, Strohm J: Bridging the divide between science and journalism. J Transl Med. 2010, 8: 25-10.1186/1479-5876-8-25.CrossRef
24.
go back to reference Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Thurin M, Trinchieri G, Wang E, Wigginton J, Chaussabel D: A systematic approach to biomarker discovery; Preamble to "the iSBTc-FDA taskforce on Immunotherapy Biomarkers". J Transl Med. 2008, 6: 81-10.1186/1479-5876-6-81.PubMedCentralCrossRefPubMed Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Thurin M, Trinchieri G, Wang E, Wigginton J, Chaussabel D: A systematic approach to biomarker discovery; Preamble to "the iSBTc-FDA taskforce on Immunotherapy Biomarkers". J Transl Med. 2008, 6: 81-10.1186/1479-5876-6-81.PubMedCentralCrossRefPubMed
25.
go back to reference Tahara H, Sato M, Thurin M, Wang E, Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Wigginton JM: Emerging concepts in biomarker discovery; The US-Japan workshop on immunological molecular markers in oncology. J Transl Med. 2009, 7: 45-10.1186/1479-5876-7-45.PubMedCentralCrossRefPubMed Tahara H, Sato M, Thurin M, Wang E, Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Wigginton JM: Emerging concepts in biomarker discovery; The US-Japan workshop on immunological molecular markers in oncology. J Transl Med. 2009, 7: 45-10.1186/1479-5876-7-45.PubMedCentralCrossRefPubMed
26.
go back to reference Butterfield LH, Disis ML, Khleif SN, Balwit JM, Marincola FM: Immuno-Oncology Biomarkers 2010 and Beyond: Perspectives from the iSBTc/SITC Biomarker Task Force. J Transl Med. 2010, 8: 130-10.1186/1479-5876-8-130.PubMedCentralCrossRefPubMed Butterfield LH, Disis ML, Khleif SN, Balwit JM, Marincola FM: Immuno-Oncology Biomarkers 2010 and Beyond: Perspectives from the iSBTc/SITC Biomarker Task Force. J Transl Med. 2010, 8: 130-10.1186/1479-5876-8-130.PubMedCentralCrossRefPubMed
Metadata
Title
Translational Medicine is developing in China: A new venue for collaboration
Authors
Xiangdong Wang
Ena Wang
Francesco M Marincola
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2011
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-9-3

Other articles of this Issue 1/2011

Journal of Translational Medicine 1/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.